CIBC Private Wealth Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Sell |
|
|||||
|
2025
Q1 | $207K | Sell |
|
|||||
|
2024
Q4 | $223K | Sell |
|
|||||
|
2024
Q3 | $424K | Sell |
|
|||||
|
2024
Q2 | $425K | Sell |
|
|||||
|
2024
Q1 | $527K | Buy |
|
|||||
|
2023
Q4 | $330K | Sell |
|
|||||
|
2023
Q3 | $334K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $9K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $680K | Sell |
|
|||||
|
2021
Q1 | $622K | Sell |
|
|||||
|
2020
Q4 | $649K | Sell |
|
|||||
|
2020
Q3 | $676K | Sell |
|
|||||
|
2020
Q2 | $1.54M | Sell |
|
|||||
|
2020
Q1 | $1.45M | Sell |
|
|||||
|
2019
Q4 | $1.88M | Buy |
|
|||||
|
2019
Q3 | $427K | Sell |
|
|||||
|
2019
Q2 | $593K | Buy |
|
|||||
|
2019
Q1 | $609K | Sell |
|
|||||
|
2018
Q4 | $971K | Sell |
|
|||||
|
2018
Q3 | $1.73M | Buy |
|
|||||
|
2018
Q2 | $1.63M | Buy |
|
|||||
|
2018
Q1 | $1.28M | Sell |
|
|||||
|
2017
Q4 | $1.33M | Sell |
|
|||||
|
2017
Q3 | $2.83M | Buy |
|
|||||
|
2017
Q2 | $2.5M | Buy |
|
|||||
|
2017
Q1 | $2.16M | Buy |
|
|||||
|
2016
Q4 | $1.92M | Sell |
|
|||||
|
2016
Q3 | $2.36M | Buy |
|
|||||
|
2016
Q2 | $2.2M | Buy |
|
|||||
|
2016
Q1 | $2.05M | Sell |
|
|||||
|
2015
Q4 | $2.18M | Buy |
|
|||||
|
2015
Q3 | $1.9M | Sell |
|
|||||
|
2015
Q2 | $2.1M | Sell |
|
|||||
|
2015
Q1 | $2.37M | Sell |
|
|||||
|
2014
Q4 | $2.31M | Buy |
|
|||||
|
2014
Q3 | $2.12M | Sell |
|
|||||
|
2014
Q2 | $2.56M | Buy |
|
|||||
|
2014
Q1 | $2M | Buy |
|